Determinants of target organ damage in black hypertensive patients attending primary health care services in Cape Town: The Hi-Hi study

American Journal of Hypertension

Volumn 21, Issue 8, 2008, Pages 896-902

  Peer, Nasheeta ^a   Steyn, Krisela ^a,b   Dennison, Cheryl R ^c   Levitt, Naomi S ^b   Nyo, Myat T L ^b   Nel, Johanna H ^d   Commerford, Patrick J ^b   Fourie, Jean M ^a   Hill, Martha N ^c  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; LOW DENSITY LIPOPROTEIN;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD EXAMINATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DRUG USE; ELECTROCARDIOGRAPHY; FEMALE; HEALTH SERVICE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; ISCHEMIA; KIDNEY FAILURE; LIFESTYLE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREVALENCE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PROTEINURIA; SEX DIFFERENCE; SOUTH AFRICA; URBAN POPULATION; URINALYSIS;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; PREVALENCE; PRIMARY HEALTH CARE; RISK FACTORS; SOCIOECONOMIC FACTORS; SOUTH AFRICA;

EID: 47749114150     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2008.210     Document Type: Article

References (29)

1. Mollentze WF, Moore A, Steyn AF, Joubert G, Steyn K, Oosthuizen GM, Weich DJV. Coronary heart disease risk factors in a rural and urban Orange Free State black population. S Afr Med J 1995; 85:90-96.
2. Steyn K, Gaziano TA, Bradshaw D, Laubscher R, Fourie JM. Hypertension in South African adults: results from the Demographic and Health Survey, 1998. J Hypertens 2001; 19:1717-1725.
3. Bradshaw D, Groenewald P, Laubscher R, Nannan N, Nojilana B, Norman R, Pieterse D, Schneider M. Initial burden of disease estimates for South Africa, 2000. South African Medical Research Council: Cape Town, 2003.
4. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004; 22:11-14.
5. Department of Health: South Africa Demographic and Health Survey 1998. Full Report. Pretoria, Department of Health, 2002.
6. Dennison CR, Peer N, Lombard CJ, Levitt NS, Hill MN, Steyn K. Cardiovascular risk and comorbid conditions among Black South Africans with hypertension receiving primary care in public and private settings: the HiHi study. Ethn Dis 2007; 17:477-483.
7. Dennison CR, Peer N, Steyn K, Hill MN. Determinants of hypertension control among peri-urban Black South Africans: the HiHi study. Ethn Dis 2007; 17:484-491.
8. Ewing JA. Detecting alcoholism: the CAGE questionnaire. JAMA 1984; 252:1905.
9. World Health Organization. Department of Chronic Disease and Health Promotion. Global Physical Activity Questionnaire (GPAQ). 〈http://www.who. int/chp/steps/GPAQ%20Instrument%20and%20Analysis%20Guide%20v2.pdf〉 Accessed 5 June 2006.
10. Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the Hill-Bone compliance to high blood pressure therapy scale. Prog Cardiovasc Nurs 2000; 15:90-96.
11. Lambert EV, Steyn K, Stender S, Everage N, Fourie JM, Hill M. Cross-cultural validation of the Hill-Bone compliance to high blood pressure therapy scale in a South African, Primary Health Care Setting. Ethn Dis 2006; 16:286-291.
12. Anatomical Therapeutical Chemical Classification (ATC) Index with Defined Daily Diseases (DDDs). WHO Collaborating Centre for Drugs. Statistics Methodology: Norway, 1998.
13. Bray GA. Definition, measurement, and classification of the syndromes of obesity. Int J Obes 1978; 2:99-112.
14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-502.
15. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41.
16. Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Int Med 1916; 17:863-871.
17. Prineas RJ, Crow RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings. John Wright-PSG: Boston, 1982, pp. 203-220.
18. Dahlof B, Devereux R, de Faire U, Fyhrquist F, Hedner T, Ibsen H, Julius S, Kieldsen S, Krisianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H. The Losartan intervention for endpoint reduction (LIFE) in hypertension study: rationale, design and methods. Am J Hypertens 1997; 10:705-713.
19. The Pooling Project Research Group: Relationship of blood pressure, serum cholesterol, smoking habits, relative weight and ECG abnormalities to incidence of major coronary events: final report of the Pooling Project. J Chronic Dis 1978; 31:201-306.
20. Rayner B, Becker P. The prevalence of microalbuminuria and ECG left ventricular hypertrophy in hypertensive patients in private practices in South Africa. Cardiovasc J S Afr 2006; 17:245-249.
21. Lepira FB, Kayembe PK, M'buyamba-Kabangu JR, Nseka MN. Clinical correlates of left ventricular hypertrophy in black patients with arterial hypertension. Cardiovasc J S Afr 2006; 17:7-11.
22. Seedat YK. Improvement in treatment of hypertension has not reduced incidence of end-stage renal disease. J Hum Hypertens 1999; 13:747-751.
23. Post WS, Hill MN, Dennison CR, Weiss JL, Gerstenblith G, Blumenthal RS. High prevalence of target organ damage in young, African American inner-city men with hypertension. J Clin Hypertens 2003; 5:24-30.
24. Elliott WJ, Meyer PM. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet 2007; 369:201-207.
25. Kadiri S, Salako BL. Cardiovascular risk factors in middle aged Nigerians. East Afr Med 1997; 74:303-306.
26. Miller NH, Hill M, Kottke T, Ockene IS. The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals. Circulation 1997; 95:1085-1090.
27. Pestana JAX, Steyn K, Leiman A, Hartzenberg GM. The direct and indirect costs of cardiovascular disease in South Africa in 1991. S Afr Med J 1996; 86:679-684.
28. Yach D, Hawkes C, Gould CL, Hofman KJ. The global burden of chronic diseases. Overcoming impediments to prevention and control. JAMA 2004; 291:2616-2622.
29. Kizer JR, Arnett DK, Bella JN, Paranicas M, Rao DC, Province MA, Oberman A, Kitzman DW, Hopkins PN, Liu JE, Devereux RB. Differences in left ventricular structure between black and white hypertensive adults: the Hypertension Genetic Epidemiology Network study. Hypertension 2004; 43:1182-1188.